United KingdomOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 790 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89,125 | 92,955 |
| Total Cites | 6,997 | 7,705 |
| H-index | 42 | 46 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 471 | 482 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 825 | 851 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 1,800 | 2,074 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,097 | 6,386 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
9.19%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 800 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87,983 | 89,991 |
| Total Cites | 6,630 | 7,295 |
| H-index | 40 | 45 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 465 | 476 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 795 | 821 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 1,668 | 1,919 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,770 | 6,043 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
9.12%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 797 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86,443 | 89,985 |
| Total Cites | 6,155 | 6,780 |
| H-index | 38 | 42 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 452 | 463 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 757 | 783 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 1,492 | 1,713 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,339 | 5,599 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
9.22%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 767 out of 94,611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84,283 | 89,854 |
| Total Cites | 5,378 | 5,929 |
| H-index | 36 | 38 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 433 | 444 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 702 | 727 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 1,218 | 1,396 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,655 | 4,886 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
9.29%
|
|
Trending Researchers
Top 2% Scientists by Country
United Kingdom18,125 scientists, 3rd in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.